Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Head and Neck Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 3 Carcinoma, Squamous Cell 2 Tongue Neoplasms 1 Thyroid Neoplasms 1 Pain, Postoperative 1 Neoplasms 1 Neoplasm Metastasis 1 Mouth Neoplasms 1 Carcinoma, Medullary 1 Carcinoma 1

Interventions

Iodine-131 14 trametinib 9 dabrafenib 9 Thyroidectomy 9 Surgical Procedures, Operative 9 lenvatinib 8 Thyroxine 8 Magnetic Resonance Spectroscopy 8 pembrolizumab 7 Paclitaxel 7 anlotinib 6 Thyrotropin Alfa 6 selpercatinib 5 Sorafenib 5 Saline Solution 5 Radiofrequency Ablation 5 Everolimus 5 pazopanib 4 Vemurafenib 4 Sunitinib 4 Radiotherapy 4 Nivolumab 4 Fluorodeoxyglucose F18 4 Dexmedetomidine 4 Cyclophosphamide 4 Biopsy, Fine-Needle 4 Biopsy 4 Bevacizumab 4 apatinib 3 Triiodothyronine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Thyroid Neoplasms × Neck Dissection × Clear all

NCT03570021 2026-03-06

ESTIMABL3

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Active not recruiting

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡